Dedicated to testing and early intervention
Peripheral Artery Disease (PAD) is a common, yet serious, disease that is often not diagnosed but can be treated.
Maintaining Healthier Legs
MakrisMD Vascular Specialists offers personal, individualized care for patients with vein disease. We use a comprehensive, non-surgical approach to treat aesthetic and therapeutic problems.
Fibroid Symptom Relief Without Surgery
We offer a minimally invasive treatment option, uterine fibroid embolization (UFE), as an alternative to surgical procedures, such as hysterectomy, for the treatment of uterine fibroids.
Minimally Invasive Treatment Options for Vascular Conditions
Our outpatient vascular access center in Oakbrook, IL offers a complete range of minimally invasive vascular procedures, including treatment options for Peripheral Artery Disease (PAD), Uterine Fibroids and Dialysis Access Management.
Meet our team of highly trained professionals
Our physicians are skilled, experienced specialists in vascular and interventional radiology. In addition to offering the highest quality medical care and latest techniques, we care about the comfort and well-being of our patients, treating them like family.
State-of-the-art Outpatient Vascular Center
All procedures are performed in our state-of-the-art outpatient interventional and vascular radiology center, conveniently located in Westmont, IL. Our facility is accredited by The Joint Commission.
10 Marriott Drive, Lincolnshire, Illinois 60069
Learn more about arterial and venous ulcers - a presentation for attendees of the Illinois Podiatric Medical Association. Click the event link for more information!
Clinical Study Recently Completed | Closed
The Bard RESCUE Trial was conducted at over 30 centers involving over 300 patients over the course of two years. The prospective, randomized, concurrently-controlled study of the Fluency Plus Endovascular stent graft was able to prove an effective treatment of in-stent restenosis in both fistulas and grafts.
Clinical Study Underway | Open
We are currently enrolling patients for a new study sponsored by Lutonix, a division of Bard, that will also monitor patient’s fistulas for two years. The prospective, global, multicenter, randomized controlled study will compare the Lutonix 035 AV drug coated balloon PTA catheter vs standard balloon PTA catheter for the treatment of dysfunctional AV fistulae.